Health Care

This week on Mostly Economics, Dean Baker talks with Sabrina Corlette, Research Professor at Georgetown University’s Center on Healthcare Insurance Reforms, about the ramifications of Trump’s one big ugly bill, which gutted Affordable Care Act coverage. 

A new policy paper identifies seven areas where financial actors and powerful industry players have exploited existing laws and regulations for private gain at the expense of patients, workers and taxpayers.

The Trump administration’s claims of widespread ACA fraud are unsupported by evidence and overlook the insurers that would profit most from fraudulent enrollments.

Healthcare costs could fall dramatically by funding research upfront and eliminating patent monopolies that drive up the price of drugs and medical equipment.

A new CEPR issue brief examines economic and social developments under Colombia’s Gustavo Petro administration and finds that there has been significant progress according to a variety of key indicators.

Pharmaceutical companies spend billions on drug advertising — a colossal waste of money that drives up medical costs and can present serious dangers to public health.

Trump’s drug pricing proposal would modestly reduce costs while keeping US drug prices among the highest in the world.

While hospital monopolies raise prices, patent protections on drugs and medical equipment are a deeper driver of high health care costs and inefficiency.

New proposals from the Congressional Progressive Caucus represent a genuine opportunity to improve worker’s lives and reduce inequality.

Donald Trump rolled out another drug pricing deal — but it’s still very unclear whether these arrangements provide any relief to consumers.